Cargando…
Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
The current vaccine for tuberculosis (TB) is a live attenuated strain of Mycobacterium bovis (BCG) and while effective at reducing the potential for disseminated TB in young children its disease protection rates in adults is highly variable while it confers little protection against latent TB. With...
Autores principales: | Strong, Emily J., West, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884834/ https://www.ncbi.nlm.nih.gov/pubmed/29618733 http://dx.doi.org/10.1038/s41598-018-23893-3 |
Ejemplares similares
-
MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
por: Melly, Geoff, et al.
Publicado: (2019) -
Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
por: McNeil, Matthew B., et al.
Publicado: (2020) -
Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosis
por: Li, Ming, et al.
Publicado: (2020) -
Two-Way Regulation of MmpL3 Expression Identifies
and Validates Inhibitors of MmpL3 Function in Mycobacterium
tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020) -
Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis
por: Yamamoto, Kentaro, et al.
Publicado: (2021)